Form 4 holding
VP Finance/Prin Fin&Acct Offic
Perspective Therapeutics, Inc.
- Security class
- Common stock
- Shares / value
- 84,030
- Estimated value
- $30,251
- Report date
- 23 Apr 2024
- Price
- $0.3600
- Ownership
- Direct
Mark John Austin - VP Finance/Prin Fin&Acct Offic at Perspective Therapeutics, Inc.
Issuer-level insider activity
- Role
- VP Finance/Prin Fin&Acct Offic
- Issuer ticker
- CATX on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Mark John Austin since 10 Jul 2025
Reported holdings for Mark John Austin in Perspective Therapeutics, Inc.
Form 4 holding
VP Finance/Prin Fin&Acct Offic
Perspective Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 34,500
- Estimated value
- Report date
- 17 Jul 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mark John Austin in Perspective Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.